GermanyHealthcare and life sciences2016 – ongoingRhön-Klinikum
IBM Watson pilot for diagnosis support in rare diseases
Rhön ended its IBM Watson diagnosis pilot in 2017 and switched to a document-analysis tool from another provider
Problem
Rare and undiagnosed diseases are hard to identify, and the hospital group wanted software to help doctors with diagnosis.
Approach
Rhön began testing IBM's Watson in early 2016, first at the centre for undiagnosed and rare diseases at Marburg university hospital and then at other Rhön hospitals. In September 2017 the group said it would not continue the cooperation after the pilot. It brought in Mindbreeze InSpire, which analyses medical documents such as discharge letters and lab and radiology reports, starting at Bad Neustadt.
Results
No published figures
Takeaway
Rhön gave no reason for stopping beyond saying it did better with several individually chosen partners. It published no results from the pilot.
Categories
- Size
- Large enterprise
- Industry
- Healthcare and life sciences
- Business function
- Internal work and knowledge management
- Innovation type
- Process innovation
- AI technology
- Predictive analytics and ML
- Adoption
- Vendor solution
- Goal
- Quality and risk
- Evidence
- Press reporting
Sources
Source summaries
The trade paper reports that Rhön will not continue its Watson cooperation with IBM after the pilot, which began in early 2016 at Marburg. A spokesperson said only that the group fares better with several individually chosen partners. The piece also reports a new document-analysis system from Mindbreeze. It gives no figures.
Full details are in the original sources.
